Literature DB >> 17515175

Induced gamma activity and event-related coherence in schizophrenia.

P Bucci1, A Mucci, E Merlotti, U Volpe, S Galderisi.   

Abstract

Evidence has been provided that high frequency oscillations within the gamma band reflect mechanisms of cortical integration. In the light of recently proposed pathophysiological models of schizophrenia, suggesting a disturbance of the functional connectivity within distributed neural networks, it has been hypothesized that abnormalities in the gamma band underlie perceptual and cognitive dysfunctions in patients with schizophrenia. In the present study we investigated evoked and induced 40-Hz gamma power as well as frontoparietal and frontotemporal event-related coherence in patients with deficit and nondeficit schizophrenia and in matched healthy controls. In patients, correlations between gamma oscillations and psychopathological dimensions were also investigated. A reduction of both induced gamma power and event-related coherence was observed in patients with nondeficit schizophrenia, but not in those with deficit schizophrenia. Our findings support the hypothesis that deficit and nondeficit schizophrenia represent separate disease entities, suggesting the presence of a poor integration of the neuronal activity within distributed neural network only in the subgroup of schizophrenic patients without primary and persistent negative symptoms. Associations between an excess of gamma oscillations and psychopathological dimensions were observed, suggesting that abnormal thoughts, behaviors and perceptions might be related to the formation of inappropriate neural connections.

Entities:  

Mesh:

Year:  2007        PMID: 17515175     DOI: 10.1177/155005940703800212

Source DB:  PubMed          Journal:  Clin EEG Neurosci        ISSN: 1550-0594            Impact factor:   1.843


  11 in total

1.  Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars.

Authors:  Francine M Benes; Benjamin Lim; David Matzilevich; Sivan Subburaju; John P Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

Review 2.  Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia.

Authors:  Anita K Roopun; Mark O Cunningham; Claudia Racca; Kai Alter; Roger D Traub; Miles A Whittington
Journal:  Schizophr Bull       Date:  2008-06-09       Impact factor: 9.306

3.  Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model.

Authors:  Kathryn M Gill; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2014-04-30       Impact factor: 5.176

Review 4.  Reviewing the ketamine model for schizophrenia.

Authors:  Joel Frohlich; John D Van Horn
Journal:  J Psychopharmacol       Date:  2013-11-20       Impact factor: 4.153

Review 5.  The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia.

Authors:  Peter J Uhlhaas; Corinna Haenschel; Danko Nikolić; Wolf Singer
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

Review 6.  The role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophrenia.

Authors:  Kathryn M Gill; Anthony A Grace
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Deficit schizophrenia: an update.

Authors:  Brian Kirkpatrick; Silvana Galderisi
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

Review 8.  Amygdalocortical circuitry in schizophrenia: from circuits to molecules.

Authors:  Francine M Benes
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Gamma oscillation in schizophrenia.

Authors:  Yong-Wook Shin; Brian F O'Donnell; Soyoung Youn; Jun Soo Kwon
Journal:  Psychiatry Investig       Date:  2011-12-08       Impact factor: 2.505

10.  Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia.

Authors:  Colin Kehrer; Nino Maziashvili; Tamar Dugladze; Tengis Gloveli
Journal:  Front Mol Neurosci       Date:  2008-04-08       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.